Spiritual Self-Schema (3-S) is a weekly 8-session, mindfulness-based, manual-guided, individual intervention targeting addiction and human immunodeficiency virus (HIV) risk behaviors that integrates cognitive behavioral strategies with Buddhist principles and clients’ religious/spiritual beliefs. 3-S is efficacious for reducing drug use and HIV risk behaviors among mixed-gender, methadone-maintained outpatients. The study goal was to conduct a preliminary evaluation of 3-S therapy among urban, low-income Latinas (n = 13) in residential addiction treatment. Data gathered via in-person interviews (baseline, 8 and 20 weeks postentry) showed high rates of 3-S acceptability and positive changes in a number of outcomes relevant to recovery from addiction and to HIV prevention, including impulsivity, spirituality, motivation for change, and HIV prevention knowledge. The study findings are promising; however, a controlled study with longer follow-up is needed to rigorously assess the efficacy of 3-S therapy with Latinas in substance abuse treatment.
National Institute on Drug Abuse. 2002. Principles of HIV Prevention in Drug-Using Populations, Bethesda, MD: National Institute of Health.
2.
GeppertC, BogenschutzM P and MillerW R. 2007. Development of a bibliography on religion, spirituality and addictions. Drug Alcohol Rev., 26: 389–395.
3.
AvantsS K and MargolinA. 2004. Development of Spiritual Self-Schema (3-S) therapy for the treatment of addictive and HIV risk behavior: a convergence of cognitive and Buddhist psychology. J Psychother Integrat, 14: 253–289.
4.
MargolinA, BeitelM, Schuman-OlivierZ and AvantsS K. 2006. A controlled study of a spirituality-focused intervention for increasing motivation for HIV prevention among drug users. AIDS Educ Prevent, 18: 311–322.
5.
AvantsS K and MargolinA. 2003. Spiritual Self Schema Therapy manualRetrieved August 5, 2007, from http://www.3-s.us/
6.
AvantsS K, BeitelM and MargolinA. 2005. Making the shift from ‘addict self to spiritual self.’ Results from a stage I study of Spiritual Self Schema (3-S) therapy for treatment of addiction and HIV risk behavior. Mental Health Religion Culture, 8: 167–177.
7.
MargolinA, Schuman-OlivierZ, BeitelM, ArnoldR M, FulwilerC E and AvantsS K. 2007. A preliminary study of Spiritual Self-Schema (3-S+) therapy for reducing impulsivity in HIV-positive drug users. J Clin Psychol, 63: 979–999.
KottiriB J, FriedmanS R, NeaigusA, CurtisR and Des JarlaisD C. 2002. Risk networks and racial/ethnic differences in the prevalence of HIV infection among injection drug users. J Acquir Immune Defic Syndr, 30: 95–104.
10.
National Institute on Drug Abuse. 2007. Hispanics and drug abuseAvailable at: http://www.drugabuse.gov/newsroom/07/NS-2.html NewsScan NIDA Addiction Research News (Feb). Accessed September 11, 2008
11.
ArévaloS, PradoG and AmaroH. 2008. Spirituality, sense of coherence, and coping responses in women receiving treatment for alcohol and drug addiction. Eval Program Plann, 31: 113–123.
12.
AmaroH, McGrawS, LarsonM J, LópezL, NievesR and MarshallB. 2005. Boston Consortium of Services for Families in Recovery: a trauma-informed intervention model for women's alcohol and drug addiction treatment. Alcohol Treat Q, 22: 95–119.
13.
McLellanA T, KushnerHMetzgerD. 1992. The Fifth Edition of the Addiction Severity Index. J Subst Abuse Treat, 9: 199–213.
14.
McLellanA T, LuborskyLCacciolaJ. 1985. New data from the Addiction Severity Index: reliability and validity in three centers. J Nerv Mental Dis, 173: 412–423.
15.
ArgeriouM, McCartyD, MulveyK and DaleyM. 1994. Use of the Addiction Severity Index with homeless substance abusers. J Subst Abuse Treat, 11: 359–65.
16.
HodginsD C and El-GuebalyN. 1992. More data on the Addiction Severity Index: reliability and validity with the mentally ill substance abuser. J Nerv Mental Dis, 180: 197–201.
17.
LeonhardC, MulveyK, GastfriendD R and ShwartzM. 2000. The Addiction Severity Index: a field study of internal consistency and validity. J Subst Abuse Treat, 18: 129–135.
18.
FoaE B, CashmanL, JaycoxL and PerryK. 1997. The validation of a self-report measure of posttraumatic stress disorder: the Posttraumatic Diagnostic Scale. Psychol Assess, 9: 445–451.
19.
DerogatisL. 1993. Brief Symptom Inventory (BSI): Administration, Scoring and Procedures Manual, 4th ed., Minneapolis: National Computer Systems.
20.
VincentC. 1990. Credibility assessments in trials of acupuncture. Complement Med Res, 4: 8–11.
21.
PattonJ H, StanfordM S and BarrattE S. 1995. Factor structure of the Barratt Impulsiveness Scale. J Clin Psychol, 51: 768–74.
22.
National Institute on Drug Abuse. 1994. Outreach/Risk Reduction Strategies for Changing HIV-Related Risk Among Injection Drug Users, Rockville, MD: NIDA. NIH Publication No. 94-3726
23.
SimpsonT L, KaysenDBowenS. 2007. PTSD symptoms, substance use, and vipassana meditation among incarcerated individuals. J Trauma Stress, 20: 239–249.
24.
BeitelM, GenovaM, Schuman-OlivierZ, ArnoldR, AvantsS K and MargolinA. 2007. Reflections by inner-city drug users on a Buddhist-based spirituality focused therapy: a qualitative study. Am J Orthopsychiatry, 77: 1–9.
25.
GómezC and MarínB. 1996. Gender, culture, and power: barriers to HIV-prevention strategies for women. J Sex Res, 33: 355–362.
26.
NyamathiA, BennettC, LeakeB, LewisC and FlaskerudJ. 1993. AIDS-related knowledge, perceptions, and behaviors among impoverished minority women. Am J Public Health, 83: 65–71.
27.
BernalG, BonillaJ and BellidoC. 1995. Ecological validity and cultural sensitivity for outcome research: issues for the cultural adaptation and development of psychosocial treatments with Hispanics. (Special Issue: Psychosocial Treatment Research.). J Abnorm Child Psychol, 23: 67–83.
